164 related articles for article (PubMed ID: 32478753)
1. Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos.
Cafora M; Forti F; Briani F; Ghisotti D; Pistocchi A
J Vis Exp; 2020 May; (159):. PubMed ID: 32478753
[TBL] [Abstract][Full Text] [Related]
2. Phage therapy against Pseudomonas aeruginosa infections in a cystic fibrosis zebrafish model.
Cafora M; Deflorian G; Forti F; Ferrari L; Binelli G; Briani F; Ghisotti D; Pistocchi A
Sci Rep; 2019 Feb; 9(1):1527. PubMed ID: 30728389
[TBL] [Abstract][Full Text] [Related]
3. Bacteriophage PEV20 and Ciprofloxacin Combination Treatment Enhances Removal of Pseudomonas aeruginosa Biofilm Isolated from Cystic Fibrosis and Wound Patients.
Chang RYK; Das T; Manos J; Kutter E; Morales S; Chan HK
AAPS J; 2019 Apr; 21(3):49. PubMed ID: 30949776
[TBL] [Abstract][Full Text] [Related]
4. Design of a Broad-Range Bacteriophage Cocktail That Reduces Pseudomonas aeruginosa Biofilms and Treats Acute Infections in Two Animal Models.
Forti F; Roach DR; Cafora M; Pasini ME; Horner DS; Fiscarelli EV; Rossitto M; Cariani L; Briani F; Debarbieux L; Ghisotti D
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29555626
[TBL] [Abstract][Full Text] [Related]
5. Activity of Bacteriophages in Removing Biofilms of
Fong SA; Drilling A; Morales S; Cornet ME; Woodworth BA; Fokkens WJ; Psaltis AJ; Vreugde S; Wormald PJ
Front Cell Infect Microbiol; 2017; 7():418. PubMed ID: 29018773
[No Abstract] [Full Text] [Related]
6. The potential of phage therapy in cystic fibrosis: Essential human-bacterial-phage interactions and delivery considerations for use in Pseudomonas aeruginosa-infected airways.
Trend S; Fonceca AM; Ditcham WG; Kicic A; Cf A
J Cyst Fibros; 2017 Nov; 16(6):663-670. PubMed ID: 28720345
[TBL] [Abstract][Full Text] [Related]
7. Bacteriophage-based therapy in cystic fibrosis-associated Pseudomonas aeruginosa infections: rationale and current status.
Hraiech S; Brégeon F; Rolain JM
Drug Des Devel Ther; 2015; 9():3653-63. PubMed ID: 26213462
[TBL] [Abstract][Full Text] [Related]
8. Studying Bacteriophage Efficacy Using a Zebrafish Model.
Cafora M; Brix A; Forti F; Briani F; Pistocchi A
Methods Mol Biol; 2024; 2734():151-169. PubMed ID: 38066368
[TBL] [Abstract][Full Text] [Related]
9. Pseudomonas aeruginosa infection of zebrafish involves both host and pathogen determinants.
Clatworthy AE; Lee JS; Leibman M; Kostun Z; Davidson AJ; Hung DT
Infect Immun; 2009 Apr; 77(4):1293-303. PubMed ID: 19168742
[TBL] [Abstract][Full Text] [Related]
10. Dual Transcriptomics of Host-Pathogen Interaction of Cystic Fibrosis Isolate
Kumar SS; Tandberg JI; Penesyan A; Elbourne LDH; Suarez-Bosche N; Don E; Skadberg E; Fenaroli F; Cole N; Winther-Larsen HC; Paulsen IT
Front Cell Infect Microbiol; 2018; 8():406. PubMed ID: 30524971
[No Abstract] [Full Text] [Related]
11. Relevance of multidrug-resistant Pseudomonas aeruginosa infections in cystic fibrosis.
Stefani S; Campana S; Cariani L; Carnovale V; Colombo C; Lleo MM; Iula VD; Minicucci L; Morelli P; Pizzamiglio G; Taccetti G
Int J Med Microbiol; 2017 Sep; 307(6):353-362. PubMed ID: 28754426
[TBL] [Abstract][Full Text] [Related]
12. Assessing Pseudomonas virulence with nonmammalian host: zebrafish.
Llamas MA; van der Sar AM
Methods Mol Biol; 2014; 1149():709-21. PubMed ID: 24818945
[TBL] [Abstract][Full Text] [Related]
13. Unveiling the early events of Pseudomonas aeruginosa adaptation in cystic fibrosis airway environment using a long-term in vitro maintenance.
Sousa AM; Monteiro R; Pereira MO
Int J Med Microbiol; 2018 Dec; 308(8):1053-1064. PubMed ID: 30377031
[TBL] [Abstract][Full Text] [Related]
14. Phage Therapy Is Effective in a Mouse Model of Bacterial Equine Keratitis.
Furusawa T; Iwano H; Hiyashimizu Y; Matsubara K; Higuchi H; Nagahata H; Niwa H; Katayama Y; Kinoshita Y; Hagiwara K; Iwasaki T; Tanji Y; Yokota H; Tamura Y
Appl Environ Microbiol; 2016 Sep; 82(17):5332-9. PubMed ID: 27342558
[TBL] [Abstract][Full Text] [Related]
15. Identification and impact on
Forti F; Bertoli C; Cafora M; Gilardi S; Pistocchi A; Briani F
Microbiol Spectr; 2023 Dec; 11(6):e0147723. PubMed ID: 37966242
[TBL] [Abstract][Full Text] [Related]
16. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
Ciofu O
APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
[TBL] [Abstract][Full Text] [Related]
17. Characterization of JG024, a pseudomonas aeruginosa PB1-like broad host range phage under simulated infection conditions.
Garbe J; Wesche A; Bunk B; Kazmierczak M; Selezska K; Rohde C; Sikorski J; Rohde M; Jahn D; Schobert M
BMC Microbiol; 2010 Nov; 10():301. PubMed ID: 21110836
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial.
Jault P; Leclerc T; Jennes S; Pirnay JP; Que YA; Resch G; Rousseau AF; Ravat F; Carsin H; Le Floch R; Schaal JV; Soler C; Fevre C; Arnaud I; Bretaudeau L; Gabard J
Lancet Infect Dis; 2019 Jan; 19(1):35-45. PubMed ID: 30292481
[TBL] [Abstract][Full Text] [Related]
19. Competition in Biofilms between Cystic Fibrosis Isolates of
Oluyombo O; Penfold CN; Diggle SP
mBio; 2019 Jan; 10(1):. PubMed ID: 30696740
[No Abstract] [Full Text] [Related]
20. A single dose of a virulent bacteriophage vB PaeP-SaPL, rescues bacteremic mice infected with multi drug resistant Pseudomonas aeruginosa.
Alvi IA; Asif M; Ur Rehman S
Virus Res; 2021 Jan; 292():198250. PubMed ID: 33259872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
